« Return to News | CROs/Service Providers

etrials 2nd Quarter Earnings Reflect Ongoing Financial Woes

Friday, August 15, 2008 06:00 AM

Just a month after etrials lost yet another key executive, the eClinical company released 2nd quarter numbers that illustrate the company’s ongoing struggles.

In the past few months, etrials has lost its chief executive officer, chief financial officer, and chief operating officer (whose position was eliminated). The Morrisville, N.C.-based company’s net loss for that same period was $2.2 million, versus a net loss of $1.3 million in the second quarter of 2007.

The gloomy earnings report comes despite a 12-month effort to embark on a “major transformation of its offerings and capabilities,” according to Robert Brill, etrials’ board chairman.

“We acknowledge that the company’s quarterly losses are unacceptable,” Brill said in this week’s investor call.

Interim CEO Chuck Piccirillo remains positive about etrials future, saying he expects revenue in the second half of 2008 to be equal to or slightly higher than the first half of the year.

“Our increase in backlog, bookings and awards are all early indicators that our news sales organization and selling strategies are beginning to take effect,” Piccirillo said in a company release. “Our strategy of aligning integrated solutions with customer needs is positioning etrials to capture an increasing share of the growing demand for eClinical solutions, particularly in the mid-tier market.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.